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Wound healing involves an orchestrated response that engages multiple processes,
such as hemostasis, cellular migration, extracellular matrix synthesis, and in particular,
inflammation. Using a murine model of cutaneous wound repair, the transcriptome
was mapped from 12 h to 8 days post-injury, and in response to a multicomponent,
multi-target natural product, Tr14. Using single-molecule RNA sequencing (RNA-seq),
there were clear temporal changes in known transcripts related to wound healing
pathways, and additional novel transcripts of both coding and non-coding genes. Tr14
treatment modulated >100 transcripts related to key wound repair pathways, such as
response to wounding, wound contraction, and cytokine response. The results provide
the most precise and comprehensive characterization to date of the transcriptome’s
response to skin damage, repair, and multicomponent natural product therapy. By
understanding the wound repair process, and the effects of natural products, it should
be possible to intervene more effectively in diseases involving aberrant repair.
Keywords: wound healing, RNA-seq, Traumeel (Tr14), multicomponent, multitarget, natural products, TGF-ß1,
transcript profiling
INTRODUCTION
The cellular and physiological events that comprise the wound healing process remain paramount
in the efforts to understand the biological mechanisms of chronic disease. Major diseases, such
as atherosclerosis, are understood in the context of aberrant wound repair (Ross, 1993). Even in
cancer, the importance of the inflammation system and wound healing has led authors to describe
tumors as “wounds that do not heal” (Dvorak, 1986).
Recent advances in systems biology have catalyzed a broad transformation in the conceptual
map of inflammation, in particular, the importance of its temporal and spatial evolution. For
example, the discovery of the resolvins and their actions within the inflammation system
have established the process of “resolution” as a defining event between “acute” and “chronic”
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inflammation, with the latter often associated with disease
progression and poor prognosis (Levy, 2010). Simultaneous with
inflammation resolution, wound healing triggers the onset of
a coordinated program of regeneration. This program involves
migration of resident fibroblasts and epithelial cells, recruitment
of adult stem cells and progenitors to the site, followed
by differentiation, extracellular matrix production, and tissue
remodeling.
Wound repair is a carefully orchestrated response that
integrates many of the aspects of embryonic development:
coordinated differentiation of progenitor cells, synchronous
migration of repair cells, and temporal patterns of cell division,
matrix production, and remodeling (Larson et al., 2010).
Early inflammation is effectively coupled to subsequent tissue
regeneration, but may also contribute to persistent scarring at the
site (Eming et al., 2007). While conventional approaches to tissue
injury focus largely on suppressing any type of inflammation,
via non-steroidal anti-inflammatory drugs (NSAIDs) and
glucocorticoids, there is increasing attention toward utilizing
multitarget therapies to reduce hyperactivity of the innate
immune system (Hwang et al., 2013). Recently, we have proposed
a general framework for understanding the scientific basis of
regulatory pathways in human disease, termed “Bioregulatory
Systems Medicine” (BrSM). BrSM provides a general model
for how underlying dysregulations could be corrected using
multicomponent products, such as Traumeel (Tr14) (Goldman
et al., 2015). Tr14 is a natural product containing 14 plant
and mineral ingredients. The exact mechanisms of action are
not known, but a number of studies suggest anti-inflammatory
(Porozov et al., 2004; Birnesser and Stolt, 2007) and antioxidative
properties (Baldwin and Bell, 2007; Zilinskas et al., 2011). Tr14
has shown effects on cellular and cytokine levels in randomized,
double-blind controlled trials (RCTs) of exercise-induced muscle
trauma (Pilat et al., 2015; Muders et al., 2016, 2017), and
demonstrated pain relief in acute ankle sprains (Gonzalez
de Vega et al., 2013), with substantial evidence indicating a
beneficial role in inflammation andwound repair (Wolfarth et al.,
2013).
The present study employed advanced, single-molecule
sequencing (SMS) of RNA (RNA-seq) to create a high resolution
map of the mouse transcriptome during wound healing,
and then uses this map to define changes resulting from
therapeutic intervention with Tr14. Transcript profiling by RNA-
seq provides a state-of-the-art and relatively bias-free view of the
transcriptome that can be used to identify promising networks
for evaluating drug actions and biological targets.
MATERIALS AND METHODS
Wound Healing Model
The ICR strain of mice in the age range of 4–6 weeks, ∼20 g
each, was used for the wound healing studies, under protocols
approved by Nantong University Animal Care Committee (PR
China). Under sedation (ketamine 100 mg/kg, xylazine 10 mg/kg
IP), the mouse dorsal/scapular region was shaved and then a 1
cm2 area was abraded with a rotary abrasive tool. Full thickness
skin tissue was recovered by sacrifice at specific times: 0, 12, 24,
36, 72, 96, 120, and 192 h after injury. Each time point of each
treatment group utilized 7 mice, for a total analysis of 224 mice.
Tissue was stored in RNAlater at−80◦C until RNA was isolated.
Treatment Conditions
The overall study design is presented in Supplementary Table 1,
describing the time points, treatment groups, and individual
samples sequenced in the study. Tr14 (Tr14-I group, 9.5 mg/ml)
or the saline vehicle (S group) were introduced as 6 subcutaneous
injections for a total of 0.1 ml in the region around the
wound using a 23G needle placed beneath the abraded area.
Other mice received the injections with the addition of twice
daily topical Tr14 ointment (0.1 ml of 34 mg/ml) to the
wound (Tr14-IO group) or the drug-free ointments control
(U group). The injectable solution (bottled in glass ampoules,
hydrolytic class I) and ointment Tr14 were manufactured by
Biologische Heilmittel Heel GmbH, Germany, according to GMP
standards. The study medication was packaged, shipped and
labeled by Biologische Heilmittel Heel GmbH, Germany. The full
description of ingredients and package labeling is available at the
fda.gov website (United States Food and Drug Administration,
2015, 2017).
RNA Isolation for RNA-Seq
Total nucleic acids, enriched for RNA, from the RNAlater-
preserved wounded mouse skin was extracted using TRIzol
(Invitrogen) using the manufacturer’s protocol. The sample was
homogenized using rotationally shearing blades (Tissue Tearer)
in a 10x volume of TRIzol. The quality and the quantity of the
resulting RNA was then measured using absorbance at 260/280
nm on a NanoDrop spectrophotometer (Thermo Scientific)
(Chomczynski and Mackey, 1995). Total nucleic acids were
DNase-treated (TurboDNAse, 1 ul, 30 min, 37◦C) and then
depleted of ribosomal RNA using the RiboZero rRNA removal
reagents (Epicentre). The quality of RNA was then re-assessed
using an Agilent 2100 Bioanalyzer RNA integrity number (RIN>
7) and the sample was quantified using a Nanodrop with a quality
threshold of A260/280 > 1.8.
Transcriptome Sequencing (RNA-Seq)
The SMS methodology for transcriptome quantification is
described by Lipson et al. (2009), and shown graphically in
Supplementary Figure 1. Ribosomal depleted RNA (200 ng) was
converted to cDNA using the Superscript III cDNA synthesis
kit (Invitrogen) and random hexamer primers, according to the
manufacturer’s procedure. The RNA remaining in the sample was
then degraded by the addition of 1 Unit RNase H and 1 Unit
RNase If (New England Biolabs). The resulting cDNA was then
purified twice on Performa Gel Filtration Columns (EdgeBio).
The concentration of the resulting cDNA was then quantified
using a Nanodrop, as previously described (Lipson et al., 2009).
To capture the cDNA on the sequencing plates, 3′ poly-A tails
were added to the cDNA (100 ng) using terminal transferase. The
captured cDNAmolecules were directly sequenced by fluorescent
nucleotides on the Heliscope single-molecule sequencer (SMS,
SeqLL, Inc).
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RNA-Seq Data Analysis
Each sequencing channel produces an average of 42
million reads per channel, or 43 million reads per sample
after double sequencing of channels with low coverage
(Supplementary Table 5E). Bioinformatics processing of
the data was done using Helisphere 1.2.740 package as previously
described (St. Laurent et al., 2013a). Reads were filtered
using filterSMS utility with default parameters to remove low
complexity sequences, such as poly-A, and short reads under
25 bp. Remaining reads (21 million on average per sample)
were then mapped to the mm9 genome (UCSC) combined
with ribosomal RNA sequences from NCBI (Accessions:
NR_003278.1, J01871.1, NR_003279.1) using indexDPgenomic
aligner (Lipson et al., 2009; St. Laurent et al., 2013a). Only
reads with single best alignment at or above the minimal
alignment score of 4.3 were considered. Up to 30% of reads
map to Ribosomal RNA sequences and are intentionally
filtered out, thereby preventing mis-mapping of those reads
to the rest of genome. On average, 7.1 million reads per
sample, or 33% of filtered reads satisfy mapping criteria—
having unique best mapping position on chr1-19, X, Y, M
(Supplementary Table 5E). Such mapped reads are called
Informative Reads in downstream analysis. Considering the
short read length, requirement of unique alignment, and
platform properties, the proportion of Informative Reads relative
to filtered reads is within the expected range. Informative
Reads were mapped to transcripts based on the knownGene.txt
file (mm9 version of the mouse genome) in UCSC Genes
database (Kent et al., 2002). The number of Informative Reads
overlapping exonic intervals in genome in each transcript
FIGURE 1 | The temporal response of the transcriptome to wounding of the mouse dermis. RNA sequencing results were analyzed at each time point (X axis) to
identify transcripts which differed significantly from the 0 h uninjured control sample. The resulting transcripts were then categorized into pre-curated ontologies, and
the ontologies with the greatest activity are plotted as a function of the probability that the ontology is activated disproportionately to a random sample of transcripts
(Y-axis, p-value, log10scale). Because an ontology may contain ∼200 transcripts, at any time point there might be transcripts that are increased or decreased in
magnitude relative to the control time point. (A) shows 4 ontologies with the highest statistical probability of being increased at the 12 h time point, whereby the
“immune response” ontology (blue line) is over-represented at a probability of ∼10−40 compared to a random set of transcripts. (B) depicts 5 ontologies that are
engaged in the 24–72 h time frame.
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TABLE 1 | Top Gene Ontologies changed at each time point.
Top 8 GO UP regulated Top 8 GO DOWN
regulated
GO Term* GO Term*
12 HR immune response regulation of system
process
defense response membrane depolarization
response to wounding regulation of muscle
contraction
cell activation regulation of heart
contraction
inflammatory response regulation of striated muscle
contraction
positive regulation of
response to stimulus
regulation of interleukin-10
production
cytokine-mediated signaling
pathway
oxygen transport
chemotaxis regulation of interleukin-4
production
24 HR cell adhesion melanin biosynthetic
process
biological adhesion melanin metabolic process
angiogenesis nucleosome assembly
vasculature development chromatin assembly
blood vessel development chromatin assembly or
disassembly
blood vessel
morphogenesis
nucleosome organization
actin filament-based
process
protein-DNA complex
assembly
regulation of cell proliferation DNA packaging
36 HR glycoprotein metabolic
process
ectoderm development
vesicle-mediated transport epidermis development
blood vessel
morphogenesis
keratinocyte differentiation
blood vessel development epithelial cell differentiation
vasculature development epidermal cell differentiation
actin filament-based
process
epithelium development
biopolymer glycosylation keratinization
glycosylation transition metal ion transport
72 HR cell adhesion ectoderm development
biological adhesion epidermis development
actin filament-based
process
epithelial cell differentiation
actin cytoskeleton
organization
keratinocyte differentiation
cytoskeleton organization epidermal cell differentiation
cell-cell adhesion keratinization
homophilic cell adhesion transition metal ion transport
membrane invagination molting cycle
(Continued)
TABLE 1 | Continued
Top 8 GO UP regulated Top 8 GO DOWN
regulated
GO Term* GO Term*
96 HR cell adhesion ectoderm development
biological adhesion epidermis development
phosphate metabolic
process
keratinocyte differentiation
phosphorus metabolic
process
epidermal cell differentiation
actin filament-based
process
keratinization
protein amino acid
phosphorylation
epithelial cell differentiation
homophilic cell adhesion hair cycle
actin cytoskeleton
organization
molting cycle
120 HR blood vessel development ectoderm development
vasculature development epidermis development
protein amino acid
phosphorylation
epithelial cell differentiation
positive regulation of
molecular function
epithelium development
phosphate metabolic
process
mesoderm development
phosphorus metabolic
process
keratinocyte differentiation
enzyme linked receptor
protein signaling pathway
epidermal cell differentiation
angiogenesis mesoderm formation
192 HR vesicle-mediated transport ectoderm development
phosphorus metabolic
process
epidermis development
phosphate metabolic
process
keratinocyte differentiation
protein amino acid
phosphorylation
epithelial cell differentiation
actin filament-based
process
epidermal cell differentiation
cell adhesion translational initiation
biological adhesion mesoderm development
homophilic cell adhesion keratinization
* Ontologies presented in order of lowest to highest p-values of Top 8.
is calculated, and converted to units of RPKM (reads per
thousand (K) nucleotides length of spliced transcript, per
million reads captured per sample) using custom Perl script.
Previous studies confirm that quantitative expression levels
generated by this process are able to detect changes of < 2-fold,
even at quite low absolute RNA abundance (St. Laurent et al.,
2013a).
Differentially Expressed Genes (DEG)
Fold-change (log2 scaled) and p-value (probability to obtain
the fold change by chance) for each transcript were compared
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between groups of samples using Welch’s test and edgeR
Bioconductor software package (Robinson et al., 2010). The
parameters were tuned to make biological properties of selected
FIGURE 2 | Time-course of RNA response to skin wounds. Upper panel: A
graphic summary of the major pathways engaged during mammalian wound
repair as adapted from Seifert et al. (2012). Lower panel: The major gene
ontologies of the transcripts regulated by wounding of the mouse skin, as
detailed in Table 1.
FIGURE 3 | The effect of Tr14 on gene expression patterns after wounding.
The RNA sequencing results were analyzed to identify transcripts that were
differentially expressed between placebo-treated controls and Tr14-treated
wounds, at each time point after injury (X axis). The effect of Tr14 on a given
ontology is shown as an aggregate gene expression score of the differentially
expressed transcripts in that GO group, expressed as the log2 ratio of the Tr14
vs. control levels, (Y axis, log2 ratio Tr14/Con). For the Muscle Contraction GO,
a total of 25 transcripts were affected covering 17 unique, non-redundant
genes. Tr14 affected 87 transcripts (51 genes) in the Response to Wounding
GO, and 9 transcripts (6 genes) in the Response to Cytokine Stimulus GO.
genes more prominent and minimize the false discovery rate
(FDR). For the comparison of Tr14-treated group (Tr14-I or
Tr14-IO) vs. placebo saline treated (S), edgeR unadjusted p-
value was required to be below 0.0005. The common dispersion,
trended dispersion and tagwise dispersion of raw (not RPKM
normalized) expression counts were considered when fitting
parameters of overdispersed Poisson model by edgeR software.
For the timecourse U vs. 0 h U comparison, the Welch’s test
was used and unadjusted p-value cutoff was required to be below
0.001. Results of comparison of U vs. U at 0 h groups with edgeR
were not used because large differences between wounded and
unwounded tissues made the results of the highly sensitive edgeR
tool too broad and unfocused.
For differentially expressed genes, the fold change between
RPKM values averaged across the samples was required to be
at least 1.41 (or 0.5 in log2 scale). Maximum 2000 differentially
expressed genes, defined in this way with the lowest p-value, were
selected for the subsequent analysis. This threshold was applied
to make gene ontology enrichment analysis comparable between
different groups, because GO analysis heavily depends on the
number of input genes. In fact, at every time point of U vs. 0 h U
timecourse the 2000 cutoff was substantially applied, which kept
the FDR below 0.025.
Systems Biology Data Analysis
To understand correlations and patterns among different
elements of the transcriptome, differentially expressed RNAs
are mapped to their respective biological pathways and
Gene Ontology (GO) categories (Harris et al., 2004) using
DAVID software (Huang da et al., 2009). Changes enriched
in individual pathways or ontologies were tested for their
statistical significance as measured by a number of hits greater
than expected by chance, with a p < 0.1, calculated using
a hypergeometric model. GOTERM_BP_DIRECT table from
“Functional annotation” output of DAVID was taken as the
result. Specific pathways were analyzed and studied with Pathway
Studio (Nikitin et al., 2003) and ExPlain software (Kel et al.,
2006).
RESULTS
Mouse Wound Healing Response to
Partial-Thickness Abrasion
The histological characterization of the partial-thickness abrasion
model employed here has been well described by others
(Gupta et al., 2014). The murine wound repair process has
recently been elegantly detailed using intravital imaging of
punch wounds to provide an excellent temporal description
of cellular migration, proliferation, and differentiation (Park
et al., 2017). Consistent with the very efficient cutaneous wound
repair processes in the mouse, there were no striking changes
in the gross morphological repair process induced by Tr14,
and so the effects observed on gene expression are likely
not due to major cellular changes in the harvested wound
regions.
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Gene Expression Profiling of the Wound
Healing Response
Although over 108,000 references relating to wound healing
exist in the PubMed database, relatively few provide data on
gene expression. Currently, the only published RNA-seq dataset
profiling a wound healing time course covers a model of bone
healing in sheep (Jager et al., 2011). To describe the changes in
the mouse skin transcriptome during normal wound healing, an
analysis of gene expression changes in the control time courses
was conducted using a combined fold-change/p-value method
at each point after injury. Collectively, the RNA-seq analysis
represents over 3.9 billion sequence reads, which is currently
among the largest RNA-seq datasets for skin wound healing in
existence, comparing favorably in scope with a recent RNA-seq
analysis of repair after cryo-induced muscle injury (Aguilar et al.,
2015).
Supplementary Figures 2A–G present Tagwise Dispersion
Plots showing the distribution of genes by expression level (X-
axis), and fold change (Y-axis) for the 12 h time-point through
the 192 h time points of the control wounds (U) relative to Time
0. Genes marked in red represent the subset that has statistically
significant fold change measurements.
Supplementary Table 2 lists the top 100 genes up or down-
regulated at each wound healing time point, their relative
expression levels as measured by normalized read counts,
and p-values. The list highlights hundreds of genes from the
major mammalian pathways critical to wound healing, such as
cytokines, modulators of tissue organization, growth factors, and
other genes active in the wound healing process.
Wound Healing Pathway Analysis
The above results demonstrate hundreds of genes up- and
down-regulated during the time course of wound healing. In
order to achieve a better systems-level understanding of how
the wound healing system engages transcripts at each phase
of repair, Gene Ontology (GO) analysis was employed. GO
facilitates a formalized, consistent vocabulary for understanding
the functional categories of many genes in a system. The
engagement of the Response to Wounding GO is demonstrated
by the modulation of 53 genes in this category at 12 h post-injury,
which is far more than would be expected randomly (14 genes
expected, p < 10−46), see Supplementary Figure 3 for details.
Figure 1 organizes these groups of transcripts according to
early, middle and late responding changes in placebo-treated
wounds (U). As expected, the 12-h time-point demonstrates
an intense signal for wound healing genes (Figure 1A). At
the 12 h time point, there is very striking engagement of the
Defense Response, Immune Response, Response to Wounding,
and the Inflammatory Response, as demonstrated by strong
over-representation of these transcripts [-log(p-value) on Y-
Axis, i.e., 40 is 1*10−40 probability that the Immune Response
transcripts could have been affected by chance alone.] Figure 1B
demonstrates that certain processes are sustained into the later
time frames with at least 80% of peak expression at 24 h or
later. Interestingly, this cluster of GO categories with sustained
engagement includes Localization of Cell, Leukocyte Activation,
Cytokine Production, Biological Adhesion, and TNF Production.
Within this 8-day period, the majority of inflammatory and
wound repair processes have engaged, and then subsided, giving
way to transcriptional programs designed to restore tissue
integrity, such as extracellular matrix synthesis and wound
contraction.
Collectively, these data demonstrate a detailed and high-
resolution picture of the transcriptional landscape of murine
wound healing. Table 1 lists the principal GO categories
regulated (up and down) at each post-wound time point.
Figure 2 summarizes these transcriptome changes and overlays
the present results onto previously published descriptions of the
progression of cutaneous wound repair, as recently reviewed
(Seifert et al., 2012).
The Effects of Tr14 on Gene Expression
during Wound Repair
The RNA-seq data indicates that Tr14 treatment produced
biologically significant and consistent changes in hundreds of
genes involved in wound healing pathways. Of note, the technical
FIGURE 4 | The effect of Tr14 on select transcripts in the interleukin pathway.
RNA sequencing data was analyzed to identify transcripts modulated by Tr14
treatment. Significant increases in three of the transcripts (A–C) in the
interleukin pathway are shown as gene expression (RPKM, Y axis) as a
function of time in hours (X axis).
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characteristics of the SeqLL/Helicos SMS technology have proven
accuracy and reproducibility even at low (1.5X) to moderate
(2X) changes in gene expression (St. Laurent et al., 2013a,b).
Published comparisons of tSMS RNA-seq to RT-PCR has
observed correlations of 0.85–0.90 between these methods (St.
Laurent et al., 2013b, 2016). Regardless of the mode of delivery,
Tr14 treatment resulted in hundreds of differentially regulated
genes compared to the Saline control group. For example, at
96 h, the Tr14-IO group resulted in 21 differentially expressed
genes from the Response to Wounding GO category, while
the Tr14-I group resulted in 31 differentially expressed genes.
Notably, these two sets overlapped by 13 genes, over 50% of the
maximum potential overlap (p < 2.1 × 10−10, Fisher’s exact test,
Supplementary Figure 4), demonstrating that 2 different forms
of Tr14 treatment produced many similar transcript changes,
while also emphasizing that topical and injectable delivery
produced somewhat different responses. Similar concurrence
between the two forms of delivery was observed in the Epithelial
Cell Differentiation GO category (Supplementary Figure 5).
Expression Changes in Key Wound Healing
Pathways Resulting from Tr14 Treatment
Differentially regulated genes, either increased or decreased by
Tr14-IO compared to control are summarized by their principal
Gene Ontologies in Figure 3. A relatively large number of gene
expression changes occur in the time-course as a result of Tr14
treatment. There was a noticeable effect of Tr14 on the Response
to Wounding and Response to Cytokines Gene Ontologies,
peaking by about 96–120 h post-injury and treatment (Figure 3).
Several categories exhibited secondary peaks at 96–120 h,
notably, Anti-apoptosis and Cell Differentiation (not shown).
Notable was a strong engagement of the Muscle Contraction
ontology at 96 h, which involves transcripts that are related to
wound contraction (Figure 3). As shown later in Figure 6, about
25% of the transcripts in the muscle contraction pathway were
affected at 96 h.
Selected Wound Repair Transcripts
Affected by Tr14
Using the time-course as an additional filter, transcripts with
changes in multiple time-points were identified because they
are more likely to be important factors in the Tr14-mediated
physiological network. In fact, the majority of these genes fall
into categories relevant to wound healing and provide potential
targets for further study of the molecular mechanisms of Tr14
action.
For example, Tr14 treatment regulates a number of genes
in the Interleukin family, which play key roles in intercellular
communication between lymphocytes and a variety of other
immune cell types. Figures 4A–C shows the relative expression
of Interleukin familymembers in Tr14-treated animals compared
to controls. Figure 4A shows that Tr14 treatment delays and
attenuates by 30–40% the strong increase (∼600-fold) in IL1ß
mRNA expression in the 12–24 h period after wounding.
Produced by monocytes and macrophages, IL1ß is an important
mediator of the inflammatory response (Mirza and Koh, 2015).
IL1ß induces cyclooxygenase-2 (PTGS2/COX2), which is a key
enzyme in the production of thromboxanes, leukotrienes, and
HETEs, which directly contributes to inflammatory pain and
hypersensitivity (Burke and Collier, 2011). The reduction of IL1ß
mRNA levels is consistent with Tr14’s known action to reduce
the pain of inflammation in other indications (Schneider, 2011;
Gonzalez de Vega et al., 2013). Other plant-derived therapeutics,
such as resveratrol, are also known to attenuate IL1ß levels after
burn injuries (Tao et al., 2015).
Figure 4B shows a comparison of mRNA expression levels of
IL18 receptor accessory protein (IL18RAP) in Tr14-treated vs.
controls. The initial wound causes an almost identical increase of
∼12-fold above baseline IL18RAP levels in treated and untreated
wounds. However, at each of the following 6 time points, the
Tr14-treated group shows a moderate, but reproducible increase
in expression levels. IL18RAP has been shown to regulate
interferon-γ production in peripheral blood monocytes (Myhr
et al., 2013), and so this increase might reflect altered monocytic
infiltration.
Figure 4C demonstrates the effect of Tr14 on IL36 expression
in the mouse wound. Several studies implicate IL36 in
inflammatory skin conditions in mice (Blumberg et al., 2007),
and in human psoriasis (Towne et al., 2011). Interestingly, the
fold-change of IL36 in treated animals increases to as much as
20-fold higher in Tr14-treated wounds at 96 h post-injury. Injury
caused as much as 10-fold inductions of IL-6, IL-8, and IL-
10 mRNA, with a relatively mild effect of Traumeel over time
(Supplementary Figure 6).
A variety of other genes important in wound healing display
changes in expression along the time course as a result of
Tr14 treatment and are listed in Supplementary Table 3. The
false discovery rate for this list is 0.159, 0.557, 0.238, 0.066,
0.024, 0.019 and 0.026 for 12, 24, 36, 72, 96, 120, and 192
h time points, respectively. Some examples include cell stress
and damage markers (NKG2-D, DNAJ B), extracellular matrix-
regulating genes (serine protease inhibitor A3F), and miRNAs
(mir543) (Figures 5A–D). NKG2D (KLRK1), for instance, is a
natural killer cell receptor which has an extensively published
connection with the innate immune response system’s ability to
detect stress and senescent cells (Sagiv et al., 2016), and thus,
along with its ligands, is considered a therapeutic target for
immune diseases (Gonzalez et al., 2008). DNAJB13 is a member
of the heat shock protein (HSP) family, and has recently been
associated with defects in cell motility (El Khouri et al., 2016).
Serine protease inhibitor A3 is likely involved in controlling
elastase activity and members of this family have been implicated
in maintaining barrier functions (Hu et al., 2013). Micro RNA
543 (mir543) has been associated with mesenchymal stem cell
differentiation, and thus may be related to changes in the cellular
differentiation pathways (Xu et al., 2017).
Principal Gene Ontology Categories
Affected by Tr14 Treatment
The Gene Ontology mapping of the RNA-seq dataset provides a
means of identifying patterns of gene expression during wound
repair. A complete list of Gene Ontology categories significantly
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FIGURE 5 | Comparison of gene expression for selected transcripts (A–D) in Tr14 treated animals vs. saline controls. The X axis reports the time after injury to the
mouse skin, when the wounded region was harvested for RNA and quantitation by RNA-seq. The Y axis reflects the average normalized gene expression for the
transcripts specified in each panel. Red lines indicate expression levels in control mice and blue lines indicate levels in Tr14-treated wounds (IO Group).
affected by Tr14-IO treatment at each time-point is included
in the Supplementary Table 4. One important group of genes
regulated by Tr14 treatment includes modulators of tissue
organization and pattern development. For instance, at 12 h
post-injury, a cluster of key modulators of the developmental
process are affected by Tr14 including Desmoglein 4 (Dsg4),
peroxisome proliferator activated receptor-γ (Pparg), and the
keratins family (Krt). Among the most intriguing Gene Ontology
categories affected by Tr14 in this study were the categories
of Muscle Contraction, Response to Wounding, and Response
to Cytokine Stimulus as shown in Figure 3, Tr14 upregulates
a relatively large number of these genes, especially during the
96–192 h time frame.
The data reveals a similar, but inverse effect of Tr14 on
the Epithelial Cell Differentiation gene ontology category at
later time points. Supplementary Figure 5 details only genes
in the Epithelial Cell Differentiation GO which are up and
down regulated in either of the two Tr14 treatment groups. At
two time-points, there is a >50% overlap in these differentially
expressed genes between the two treatment groups, and with a
highly significant p-value. Overall, the broad changes in cellular
differentiation genes in Tr14 treated groups suggests an enhanced
regulation of the differentiated state in the microenvironments
of Tr14-treated wounds. This effect would increase the repair
capacity in the area of the wound, and could explain another
fundamental aspect of Tr14’s therapeutic effect.
Network Analysis Provides Hypotheses for
Tr14 Mode of Action
While GO Categories represent broad collections of genes
grouped by biological functions, effectively a “Parts List,”
biological networks equate to detailed “Wiring Diagrams”
that include regulatory circuits, feedback loops, and control
elements. The Muscle Contraction ontology was selected for
further analysis because it was strongly affected by Tr14, and
it is a well-characterized network of genes with a common,
well-defined function. To analyze Muscle Contraction in the
form of a network, we developed a methodology to filter
network nodes and edges collected from the literature by
selecting only differentially expressed nodes for the final
network representation, which would emphasize nodes that are
susceptible to regulation. At 96 h, 65 of the 249 transcripts in
this pathway were affected by Tr14 treatment, which is vastly
larger than would be expected by chance alone (p = 7.8 ×
10−29). The resulting Muscle Contraction network, depicted at
the 96 h time point in Figure 6, shows a set of transcripts that are
associated with wound contraction and regulated upward (red)
or downward (blue). Thus, using this preconstructed pathway
(Nikitin et al., 2003) as a molecular map, it could be concluded
that transcripts in the wound contraction pathway are affected by
Tr14 treatment, possibly contributing to a therapeutic effect of
Tr14.
Frontiers in Molecular Biosciences | www.frontiersin.org 8 August 2017 | Volume 4 | Article 57
St. Laurent III et al. Multicomponent Tr14 Affects Wound Transcriptome
FIGURE 6 | Muscle Contraction Gene Network at 96 h. Transcripts affected by Tr14 treatment were analyzed for their relevance to a series of pre-established
biological pathways as described in Methods (Systems Biology). A greater than expected number of transcripts belonged to the Muscle Contraction pathway, which
likely reflects wound contraction processes. In this pathway, reconstructed from the literature by Pathway Studio software (Nikitin et al., 2003), individual transcripts
described by their standard gene symbol are connected by lines. Lines may connect genes if one gene product is known to induce the expression of another, if
products interact directly, or if one product is a substrate for the other. Transcripts that are increased by Tr14 are highlighted in RED, while transcripts that decreased
are shown in BLUE.
DISCUSSION
The physiological process of wound healing provides an
integrated model for injury, inflammation, and repair. As the
most extensively annotated non-human mammalian genome,
the mouse provides many advantages for genomic studies,
especially in the extensive ontologies and pathways available for
a Systems Biology analysis. The systems biology of wound repair
involves many of the processes which can become dysregulated
in chronic diseases. Tissues affected by chronic diseases display
physiological processes similar to those involved in aberrant
wound healing, including the tendency toward fibrosis and lack
of effective healing.
This study of the transcriptome during wound repair, and
Tr14 treatment, explores for the first time the changes in
genomic expression patterns resulting from a multicomponent,
multitarget medication in the context of a complex physiological
process critical to disease treatment. The study includes a
database of almost 4 billion sequence reads covering 224 animals,
4 conditions, and 8 time-points. With respect to read depth, time
points, and biological replicates, it is among the largest RNA-seq
studies conducted in wound healing completed to date, and the
first involving a multicomponent therapy.
The results indicate that a number of important gene
expression networks are involved in wound healing. These
changes arguably reflect two general types of changes: (1) changes
in the gene expression of the cells in injured tissue, and (2) the
influx of new cell types into the wounded area. The influx of
new cell types in response to skin damage, such as macrophages
and lymphocytes, likely influences the expression of a number
of regulated genes. Likewise, paracrine signaling, cell death, and
reprogramming of the cellular state also generate coordinated
changes in gene expression within resident cells of the wound
tissue.
Tr14 treatment results in extensive gene expression changes
during wound healing, including well-known pathways, such as
TGF-β, cytokine signaling, inflammation, wound contraction,
collagen, and enzymes of the extracellular matrix. Interestingly,
both of the Tr14-treated groups revealed broad and statistically
significant changes in three Gene Ontology groups of great
importance to wound healing: Response to Wounding, Response
to Cytokines, and Muscle/Wound Contraction. These signals
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may indicate effects upon resident fibroblasts and infiltrating
immune cells, which could easily have been overlooked in simpler
experimental models. This result agrees with clinical evidence
that Tr14 therapy improves a variety of musculoskeletal injuries,
including the associated pain and swelling (Schneider, 2011).
The evidence of broad regulation of genes in these three
Gene Ontology categories has interesting implications for the
mode of action of Tr14. The patterns of expression changes
shared by Tr14-IO and Tr14-I treatments suggest two intriguing
hypotheses for Tr14 action in diseased tissue. The consistent
regulation of many genes related to cell differentiation suggests
an effect on the cellular state in the microenvironment of the
wound. The net effect could promote a more effective transition
to a less differentiated, more pluripotent state among cells in the
microenvironment. At the same time, changes in expression of
“Cell motility” genes suggest that Tr14 facilitates cell migration
and tissue organization during the wound healing process.
Increased support of pluripotency could be synergistic with the
facilitation of cell mobility to improve tissue regeneration in a
variety of disease and damage contexts.
Combined, the present studies demonstrate that while Tr14
had no observable effect on morphological repair of mouse skin,
it had a clear effect on gene expression in the wound. Mice, like
most rodents, have very efficient wound repair mechanisms, and
rarely exhibit the types aberrant scarring that can be common in
humans (Rittie, 2016). Thus, one should interpret mouse wound
healing studies with caution in respect to potential beneficial
effects in humans. It is reasonable to speculate that the changes
in gene expression observed in this rodent model indicate that
this multicomponent, multitarget therapy has perceivable effects
on key aspects of wound repair, and should be studied further in
human skin disorders and other inflammatory conditions.
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Supplementary Figure 1 | The schematic workflow of RNA sequencing using
the SeqLL true Single Molecule Sequencing (tSMS) method. Total RNA from
RNAlater-preserved skin samples at the wound site was isolated by Trizol, and
then depleted of ribosomal RNA (riboRNA) prior to fragmentation for RNA-seq.
The fragments are tailed with polyA to allow capture by polyT strands on the
sequencing plate. True Single Molecule Sequencing was conducted producing
about 42 M total reads, and ∼21 M short reads (25–65 nt) per channel, after
filtering. The filtered short reads are aligned to the mouse genome and then reads
within exons are counted and summed per transcript. The raw read count is
adjusted for the length of the transcript and the total number of aligned reads
obtained for that sample.
Supplementary Figure 2 | (A–G) Tagwise dispersion plots of wound-related
transcripts in untreated control mice at specified times after injury. RNA-seq data,
expressed as RPKM, was analyzed for differential expression between the 0 h,
unwounded, and specific time points afterward. The log2 RPKM gene expression
for each transcript (red or blue circle) is ratioed between sample time points to
create differential expression as a fold change (Y axis) vs. the absolute level of
expression of the transcript (X axis). Transcripts highlighted in red are the top
2,000 most differentially expressed (DE) between the stated time points.
Supplementary Figure 3 | Graphic Representation of the intensity of the
Response to Wounding GO category at specific time points of the wound healing
response. Details of total transcripts affected (hits), total transcripts in pathway,
hits expected by chance, and p-value, for the Response to wounding/Wound
Healing GO category, at each time point.
Supplementary Figure 4 | The effect of Tr14 treatment on transcripts in the
Response to Wounding GO. Upregulated transcripts were calculated between
Tr14 vs. saline-treated controls at each of the time points specified as described in
Materials and Methods except a p-value threshold of 0.01 was applied. The
upregulated transcripts were analyzed for preferential enrichment of the Response
to Wounding GO. The two types of Tr14 treatment are shown in separate columns
and the overlapping transcripts with Fisher’s exact test p-value are counted in the
right columns.
Supplementary Figure 5 | The effect of Tr14 treatment on transcripts in the
Epithelial Cell Differentiation GO. Details are similar to Supplementary Figure 4
except that both up and down-regulated transcripts in the Epithelial Cell
Differentiation GO were analyzed.
Supplementary Figure 6 | The effect of partial-thickness abrasion and Tr14
treatment on IL6, IL8, and IL10 mRNA levels. The levels of 3 well-characterized
interleukins is shown over time after injury of the mouse skin. Control wounds
treated with saline (S), are compared to wounds treated with Tr14 as a
combination of injections and topical treatment as specified (IO, labeled G here).
Supplementary Table 1 | Overall study design, describing the time points,
treatment groups, and individual samples sequenced in the study.
Supplementary Table 2 | The top 100 differentially expressed in control wounds
compared to the unwounded, 0 h time point. RNA-seq data was analyzed to
identify transcripts affected by abrasive wounding of the mouse skin at the
specified time points. Differentially expressed transcripts were identified by
statistical comparison using Welch’s test (P-value). The fold change of the
difference between expression levels is reported as a log2 value (Log2Fold). The
absolute level of expression for each UCSC ID transcript is described for each
time point in RPKM. The top 100 transcripts elevated (0 < 12 h) or decreased (0
> 12 h) is listed for each tested time point.
Supplementary Table 3 | Differentially expressed transcripts in Tr14-treated
wounds compared to control. RNA-seq data was analyzed to identify
transcripts modulated by Tr14 during wound repair. The transcripts with the p
< 0.0005 and a fold-change > 1.41 are shown for each of the time points
from 12 to 192 h. For each time point, the RPKM values are shown for each
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sample and each UCSC ID. The log2 fold change and P-value by EdgeR are
also shown for each transcript.
Supplementary Table 4 | Gene ontology (GO) categories for differentially
expressed genes affected by Tr14 treatment of wounds over time. RNA-seq data
was analyzed to identify transcripts modulated by Tr14-IO during wound repair, as
shown in Supplementary Table 3. The transcripts were then organized using
DAVID (Huang da et al., 2009) into Gene Ontologies that covered those transcripts
at each time point post-injury.
Supplementary Table 5 | Raw data for RNA sequencing analysis of mouse
wound repair. The raw RPKM data for gene expression for all groups, animals, and
time points is reported in the following tables. (A) Reports the (U) group of placebo
treated animals, (B) reports the (S) saline injected control group, (C) reports the (I)
Traumeel injection group, and (D) reports the (IO) Traumeel injection plus the
Traumeel ointment group. (E) Reports a summary of the sequencing data with
respect to total raw reads, filtered reads, Informative Reads and the number of
expressed transcripts for each sample in the study, by group.
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